Purpose: The aim of the present study was to assess the association between the pre-operative plasma fibrinogen level and the adjacent organ involvement in advanced gastric cancer. Materials and Methods: A total of 923 pre-operative plasma samples were obtained from 923 patients diagnosed clinically as having advanced gastric cancer, and fibrinogen levels were measured by immunoassay. Associations between fibrinogen levels and clinicopathologic findings (depth of tumor, adjacent organ involvement, and lymph node metastasis), along with survival were examined by univariate and multivariate analyses. Results: Tumor size, tumor depth, and the presence of lymph node metastasis were found to be positively correlated with the preoperative plasma fibrinogen levels (P<0.001). Fifty (5.4%) patients had adjacent organ involvement. Lymphatic invasion (P<0.001), tumor size (P<0.001), clinical T (depth of invasion) stage (P<0.001), and clinical nodal stage (P=0.018) were found to be associated with adjacent organ involvement. Univariate and multivariate regression analyses showed that a preoperatively elevated plasma fibrinogen level was associated with adjacent organ involvement (P<0.001, 0.028), and Kaplan-Meier analysis showed that it was associated with poorer survival (P<0.001). Conclusions: Plasma fibrinogen was found to be a clinically useful marker of adjacent organ involvement and overall survival. When a high fibrinogen level is encountered, preoperatively, adjacent organ involvement should be suspected in clinically advanced gastric cancer.
Introduction
Accurate pre-operative diagnosis is a prerequisite for optimal treatment planning in gastric cancer. Furthermore, in advanced gastric cancer (AGC), it is important that adjacent organ involvement be detected pre-operatively to enable patients to be properly informed and to avoid unnecessary resection. Extended local resection in AGC has been reported to increase survival, but also substantially increases morbidity, and thus, adequate information on adjacent organ involvement can helpfully decrease morbidity. (1, 2) The sensitivities of multidetector computed tomography (CT) and endoscopic ultrasound (EUS) for adjacent organ invasion have been reported to be slightly in excess of 60%. (3) (4) (5) On the other hand, the sensitivity of staging laparoscopy for metastatic lesions, in terms of peritoneal seeding or liver metastasis, is 91.7%, but its sensitivity for adjacent organ involvement is only 40%.(6) Thus, another useful tool or marker for detecting adjacent organ involve-ment is required.
Fibrinogen is a 340-kDa protein, that is converted to fibrin by the proteolytic action of thrombin, which is primarily produced by the liver. (7) In addition to its well-known roles in blood coagulation, recent studies have shown that fibrinogen plays important roles in a variety of processes, which include cell-to-cell interactions, inflammation, and cancer progression.(7-9) Elevated fibrinogen can enhance augment lymphatic and hematogeneous metastasis of advanced gastric cancer, which is major determinant of the prognosis in T2 gastric cancer. (10) In a previous study, we found that pre-operative plasma fibrinogen level is a useful marker of extent of tumor progression in gastric cancer.(11) However, few studies have evaluated the relationship between pre-operative plasma fibrinogen levels and tumor extent in gastric cancer.
Accordingly, the present study was undertaken to assess the association between pre-operative plasma fibrinogen levels and adjacent organ involvement in advanced gastric cancer.
Materials and Methods
In the present study, we retrospectively analyzed a prospective with other cancer history were excluded to avoid bias in the present study. As a result, 923 patients were included in this study. The preoperative diagnostic tools used were esophagogastroduodenoscopy (EGD) with biopsy, abdominal and pelvic CT, chest radiography, and a basic blood testing including fibrinogen level as institutional guidelines.(12,13) Pre-operative fibrinogen levels were measured before surgery using 5 ml whole blood samples drawn from an antecubital vein using a tourniquet, a 20-gauze Vacutainer needle, and The present study was performed in accordance with the guidelines issued by our institutional review board, which approved the study protocol and waived the requirement for informed consent. 
Statistical analysis
Various clinicopathologic and therapeutic factors, including fibrinogen level, were analyzed using the Chi-square test and the student's t-test. Spearman's rank correlation coefficients were used to examine associations between pairs of variables. Independent variables were entered into a logistic regression model to examine the nature of the relation between fibrinogen level and adjacent organ involvement. Survival was estimated using the Kaplan-Meier method with the log rank test. The statistical analysis was carried out using SAS version 9 (SAS Institute Inc., Cary, NC, USA). All P-values were two sided, and statistical significance was accepted for P-values of less than 0.05.
Results

Patient characteristics
The characteristics of the study population are listed in Table   1 . The median age of the 923 patients was 60 years (range; 49~67 years), and there were 624 (67.6%) males and 299 (32.4%) females.
Median tumor size was 5.5 cm (range 4.0~8.0 cm), and 805 (87.2%) patients were found to have AGC by pathologic examination.
Fibrinogen levels and correlations with clinico pathologic factors
The median fibrinogen level was 327.0 mg/dl (Interquartile range, IQR 273.0~407.0 mg/dl). Two hundred and forty nine (27.3%) patients had an elevated fibrinogen level (＞400 mg/dl).
Elevated fibrinogen level was found to be positively correlated with the following clinicopathologic parameters; age, tumor size, depth tumor, and lymph node metastasis (P＜0.001) ( Table 2 ).
3. Associations between adjacent organ involve ment and clinicopathologic factors and fibrino gen levels Table 3 A receiver operating characteristics curve for preoperative fibrinogen level and the prediction of adjacent organ involvement is shown in Fig. 1 ; the area under the curve was 0.663. Adjacent organ involvement was observed in 4 of the 432 cT2 (0.9%) patients, in 35 of the 462 cT3 (5.6%) patients, and in 11 of the 29 cT4 (37.9%) patients (Fig. 1). level (P=0.028) were all found to be significantly associated with adjacent organ involvement in clinically diagnosed AGC patients.
Multivariate logistic regression analysis and adja cent organ involvement
Survival and preoperative fibrinogen levels
Patients were followed-up until death or until June 30, 2008.
The median follow-up period for the 923 patients that remained alive at the cut-off date was 40 months. Fig. 2 shows the association between preoperative plasma fibrinogen level and overall survival. Higher levels of preoperative fibrinogen were found to be associated with a poorer prognosis by Kaplan-Meier analysis with the log-rank test (P＜0.001).
Discussion
In the present study, we assessed pre-operative plasma fibrinogen levels in 923 patients with clinically diagnosed AGC and attempted to determine the correlation between fibrinogen levels and adjacent organ involvement. The main findings of this study were:
1) pre-operative plasma fibrinogen levels in AGC patients are associated with depth of invasion, lymphatic invasion, age, tumor size, and histology; 2) pre-operative fibrinogen levels are associated with adjacent organ involvement in clinically advanced gastric cancer; and 3) higher pre-operative plasma fibrinogen levels are associated with a poor prognosis.
Although no clear mechanism was identified, fibrinogen is known to be a major acute phase protein, and to be present in Values are presented as mean±standard deviation or n (%). *Third quartile of pre-operative fibrinogen level is 407 mg/ml. Values are presented as n (%). The ability to assess adjacent organ involvement during or prior to surgery is important in terms of therapeutic decision-making.
If gastric cancer has invaded adjacent organs, such as, the spleen, pancreas, colon, liver, or diaphragm, combined resection with a negative resection margin may be possible. However, combined resection has also been reported to be an independent predictor of a higher operative morbidity rate.(2,26) Accordingly, combined resection without adjacent organ involvement in an arbitrary situation increases the risk of surgical complications due to unnecessarily expansive surgery. Our findings suggest that preoperative fibrinogen level is an important consideration in clinically advanced gastric cancer, because it might help avoid unnecessary wide surgery. The relation found in the present study between poor overall survival and a higher preoperative fibrinogen level is consistent with that found by Yamashita et al. (10) To the best of our knowledge, the present study is the first to suggest an association between pre-operative plasma fibrinogen levels and adjacent organ involvement. More limited surgery and adjuvant therapy might be indicated in patients with a higher fibrinogen level. Furthermore, the functional inhibition of fibrinogen might represent a novel therapeutic approach in AGC. In the present study, pre-operative plasma fibrinogen was found to a useful clinically marker of adjacent organ involvement and overall survival. Moreover, when pre-operative fibrinogen is high, surgeons should consider adjacent organ involvement in clinically AGC patients. Finally, pre-operative fibrinogen may be a prognostic indicator in patients with gastric cancer.
